Skip to main content
. 2016 Jul;90(1):203–211. doi: 10.1016/j.kint.2016.03.027

Table 1.

Characteristics of study patients with either an HNF1B intragenic mutation or 17q12 microdeletion

HNF1B mutation
(n = 18)
17q12 microdeletion
(n = 20)
P
Age, yr 19 (13, 45) 15.5 (11, 35) 0.3
Sex M 8 (44%), F 10 (56%) M 8 (40%), F 12 (60%) 1
Ethnicity White 18 (100%) White 19 (95%), mixed 1 (5%) 1
Indices of Deprivation 2007 score 25 (16, 46) 21 (12, 30) 0.4
Renal phenotype
Renal abnormality
 Cysts/cystic dysplasia 12 (67%) 17 (85%) 0.3
 Othera 4 (22%) 3 (15%)
 Unknown 2 (11%) 0
Age at diagnosis of renal disease, yr 0 (0, 20) 0 (0, 24) 0.7
Renal replacement therapy 3 (17%) 1 (5%) 0.3
GFR, ml/min/1.73 m2 42.6 (31, 60) 81.4 (56, 91) 0.002
Proteinuriab,c 2 (13%) 2 (11%) 1
Serum magnesium,cmmol/l 0.7 (0.67, 0.75) 0.58 (0.53, 0.69) 0.01
Hypomagnesemiac,d 6 (40%) 12 (63%) 0.3
Hyperuricemiac,e 10 (67%) 3 (16%) 0.004
 Gout 6 (33%) 2 (10%) 0.1
Extra-renal phenotype
Pancreas
 Diabetes 7 (39%) 8 (40%) 1
 Age at diagnosis of diabetes 19 (18, 37) 29 (17, 32) 1
 Pancreatic hypoplasiaf,g 1 (6%) 5 (25%) 0.2
 Fecal elastase, μg/g stool 402.5 (170, 500) 280 (167, 433) 0.8
Genital tract
 Genital tract malformationg,h 1 (6%) 2 (10%) 1
Liver
 Abnormal liver function testsg 5 (28%) 6 (30%) 1

Values are median (IQR) or n (%). Bold P-values are statistically significant.

F, female; GFR, glomerular filtration rate; IQR, interquartile range; M, male.

a

Other renal structural abnormalities included single kidney, collecting system abnormalities, and bilateral hydronephrosis.

b

Proteinuria defined as albumin-creatinine ratio >30 mg/mmol or protein-creatinine ratio >50 mg/mmol.

c

Only assessed in individuals with native renal function.

d

Hypomagnesemia defined as serum magnesium <0.7 mmol/l.

e

Hyperuricemia defined as serum urate level above upper limit of normal reference range for age and sex from analyzing laboratory.

f

Hypoplasia of body and/or tail of pancreas.

g

Not systematically assessed for.

h

Genital tract malformations included (i) unilateral undescended testicle and blind-ending epididymis, (ii) bilateral undescended testicles, and (iii) bicornuate uterus.